JOHANNESBURG, 10 February 2021 – Public health officials in South Africa have announced a change in plans in the inoculation of its citizens against COVID-19.

The Johnson & Johnson vaccine will be used to vaccinate health workers and other at-risk elderly South African, the country’s health minister, Zweli Mkhize, said Tuesday.

AstraZeneca's Dark Spot in the Light of Hope Offered by COVID19 Vaccines - Photo Reuters/Ueslei Marcelino

A Dark Spot in the Light of Hope Offered by COVID19 Vaccines, including AstraZeneca/Oxford’s – Photo Reuters/Ueslei Marcelino

Officials expect to move forwardalthough the Johnson & Johnson vaccine has not yet been approved in South Africa.

The country’s vaccination plan was put on hold after tests showed that the AstraZeneca vaccine was less effective against the South African variant of the virus.

Doses of the Pfizer vaccine have also been secured for inoculation in South Africa.

Mkhize said South Africa is considering selling the doses of the AstraZeneca vaccines to another country.

At a press conference, Mkhize said his department is waiting to be advised by South African scientists on what exactly to do with the less effective doses.

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team. This month, a reverting one on one interview with the Chairman on African Affairs at IMF

You have Successfully Subscribed!